Adducin 3
ADD3proteinADD3 maintains cardiomyocyte sarcomeric integrity and contractility, with expression changes predicting post-infarction ventricular remodeling.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationalePost-AMI heart-failure prediction biomarker; cytoskeletal protein; regulates cardiomyocyte mechanical stability.
Also acts inEndothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000148700
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction.BMC medical genomics · 2021 · PMID 33563285 · doi